Genome-Wide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy
      QxMD      Google Scholar   
Citation:
Clin Pharmacol Ther vol 108 (3) 625-634
Year:
2020
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Meta-Analysis
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
10
Parents:
2799  
Children:
None
Program:
TRP
Primary Committee:
PPP
Sec. Committees:
   
Pharmas:
Abraxis, Bristol-Myers, and Celgene  
Grants:
U10CA180821, U10CA180882, U24CA196171, UG1CA233320, UG1CA233327, R01 CA192156, T32 GM007175, P01CA142538  
Corr. Author:
 
Authors:
                                     
Networks:
CA824, DE012, LAPS-IL036, LAPS-IL057, LAPS-MA036, NY018   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-40101, CALGB-40502
Phases:
3
Keywords:
chemotherapy, sensory peripheral neuropathy, chemotherapy-induced peripheral neuropathy, genome-wide association, pharmacogenetics, S1PR1